Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Murphy

Showing results (191-200 of 643) with videos related to

Pageof 65
Sort By:
Psychiatry Research|August 1, 1981
Central cholinergic-adrenergic imbalance in the regulation of affective stateL J Siever, S C Risch, D L Murphy
Neuropharmacology|November 1, 1990
Lithium-selective alteration of the function of brain versus cardiac Gs proteinG Schreiber, S Avissar, C S Aulakh, et al.
European Journal of Pharmacology|January 21, 1992
Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonistsG Bagdy, A F Sved, D L Murphy, et al.
Anxiety|January 1, 1996
Hypervigilance in patients with obsessive-compulsive disorderC L Wiggs, A Martin, M Altemus, et al.
Psychopharmacology Bulletin|January 1, 1985
A new postsynaptic serotonin receptor agonist suitable for studies in humansE A Mueller, D L Murphy, T Sunderland, et al.
Psychopharmacology|April 11, 1979
Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluationS Lipper, D L Murphy, S Slater, et al.
American Journal of Medical Genetics|July 26, 1996
Intact coding region of the serotonin transporter gene in obsessive-compulsive disorderM Altemus, D L Murphy, B Greenberg, et al.
The American Journal of Psychiatry|November 1, 1979
Tyramine infusions in bipolar illness: behavioral effects and longitudinal changes in pressor sensitivityD Pickar, R M Cohen, D L Murphy, et al.
Psychopharmacology|January 1, 1985
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatoneN A Garrick, T Seppala, M Linnoila, et al.
Endocrinology|November 1, 1989
Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious ratsG Bagdy, A E Calogero, D L Murphy, et al.
Pageof 65

Showing results (191-200 of 643) with videos related to

Sort By:
Pageof 65
Psychiatry Research|August 1, 1981
Central cholinergic-adrenergic imbalance in the regulation of affective stateL J Siever, S C Risch, D L Murphy
Neuropharmacology|November 1, 1990
Lithium-selective alteration of the function of brain versus cardiac Gs proteinG Schreiber, S Avissar, C S Aulakh, et al.
European Journal of Pharmacology|January 21, 1992
Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonistsG Bagdy, A F Sved, D L Murphy, et al.
Anxiety|January 1, 1996
Hypervigilance in patients with obsessive-compulsive disorderC L Wiggs, A Martin, M Altemus, et al.
Psychopharmacology Bulletin|January 1, 1985
A new postsynaptic serotonin receptor agonist suitable for studies in humansE A Mueller, D L Murphy, T Sunderland, et al.
Psychopharmacology|April 11, 1979
Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluationS Lipper, D L Murphy, S Slater, et al.
American Journal of Medical Genetics|July 26, 1996
Intact coding region of the serotonin transporter gene in obsessive-compulsive disorderM Altemus, D L Murphy, B Greenberg, et al.
The American Journal of Psychiatry|November 1, 1979
Tyramine infusions in bipolar illness: behavioral effects and longitudinal changes in pressor sensitivityD Pickar, R M Cohen, D L Murphy, et al.
Psychopharmacology|January 1, 1985
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatoneN A Garrick, T Seppala, M Linnoila, et al.
Endocrinology|November 1, 1989
Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious ratsG Bagdy, A E Calogero, D L Murphy, et al.
Pageof 65